Eli Lilly to Acquire Merida Biosciences in $2.875B Deal to Advance Precision Immunology
Eli Lilly and Company has entered into a definitive agreement to acquire Merida Biosciences, Inc., a privately held biotechnology company developing precision antibody-based therapies...
Ambuja Neotia Healthcare Announces Investment to Set Up 120-Bed Woman and Child Hospital in Howrah
Ambuja Neotia Healthcare Venture Ltd (ANHVL) has unveiled plans to establish a 120-bed specialized woman and child care hospital in Howrah, West Bengal, committing an investment...
AbbVie Submits Regulatory Application to EMA for Subcutaneous Induction of SKYRIZI®️ in Crohn’s Disease
AbbVie announced the submission of a regulatory application to the European Medicines Agency (EMA) seeking approval for SKYRIZI® (risankizumab) for subcutaneous (SC) induction dosing...
FDA Approves Takeda’s First-in-Class Therapy MIMRYLO for Polycythemia Vera Following Robust Phase 3 Results
Takeda announced that the U.S. Food and Drug Administration (FDA) has approved MIMRYLO, a first-in-class therapy indicated for the treatment of polycythemia vera. Polycythemiavera is a rare, chronic...
Maharashtra FDA Withdraws Drug License Cancellation Order for Cipla C&F Unit Following Bombay High Court Rebuke
In a major regulatory development, the Maharashtra Food and Drug Administration (FDA) has withdrawn its order cancelingthe drug sale license of Cipla Pharma & Life Sciences Ltd’sCarrying and...
Orsini Partners with Priovant to Support Access to New Dermatomyositis Therapy LISRAYA
Orsini, a specialty pharmacy known for its work in rare disease care, has been named a specialty pharmacy partner for LISRAYA (brepocitinib), a newly...
